The All Wales Therapeutics and Toxicology Centre (AWTTC) has worked in conjunction with Health Education and Improvement Wales (HEIW) on a new module that launched in June.
The collaboration with HEIW comes as part of the AWTTC’s work to improve health outcomes for patients and provide educational support to healthcare providers. The module, which is the first of its kind, was launched on 11 June 2020 allowing medical professionals to gain an overview of the All Wales Medicines Strategy Group National Prescribing Indicators for 2020-2021.
"We are thrilled to have worked with HEIW on this new module and look forward to exploring many others in the future," stated Claire Thomas, Senior Pharmacist, All Wales Therapeutics and Toxicology Centre.
National Prescribing Indicators (NPIs), which now form a benchmark for safe and optimised prescribing, were first endorsed by the All Wales Medicines Strategy Group (AWMSG) in 2003. Since then NPIs have evolved to include secondary and primary care, drawing on data from a variety of sources.
The new module outlines the NPIs for 2020-2021, which have been refreshed to focus on three priority areas – analgesics, anticoagulants in atrial fibrillation and antimicrobial stewardship; supported by safety and efficiency domains.
AWTTC’s collaborative work with HEIW provides a vital resource on safe, quality and cost efficient prescribing. For more information visit: https://gpcpd.heiw.wales/clinical/national-prescribing-indicators/